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Can We Engineer Our Way to Good Health?
Russell T. Carr, Professor of Chemical Engineering
Abstract
Engineering technologies contribute to our health. Purification of drinking water has been of great benefit 
to public health. Large-scale production of penicillin is another engineering triumph that improved our 
health.
Medical imaging technology has come a long way since the X-ray. Ultrasound and MRIs are now com-
monplace. Can imaging technologies be used in new ways in our search for better health? Computer simu-
lations promise greater understanding of physiologic processes in disease and health. Simulations require 
quantitative mathematical models of physiology.
Digital wireless communications can be used to build a national medical database. The benefits of such 
a database are great. What challenges must be overcome to make this a reality? The current identity-theft 
problem indicates that security and privacy are significant hurdles.
Chemistry is now being miniaturized, much like electronics were 50 years ago. EMTs could use “lab-on-
a-chip” devices to get an “instantaneous diagnosis” from a drop of blood. Understanding of fluid behavior 
and chemical reaction on the micro-scale is required to develop a working “lab-on-a-chip.”
The April 1999 issue of Scientific American gave a glimpse of how “tissue engineering” might help health 
care. “Apligraf,” a tissue engineered skin product, is a shining success. Other efforts have been less success-
ful. After more than 30 years, the search for a small-bore vascular prosthesis continues.
Unfortunately, the more technology we introduce into health care, the more expensive it becomes. Can 
we make these technologies affordable?
undertaking. Even in “developed” countries, continued 
vigilance on water purification is required. There was 
a five-year epidemic of cholera in Latin America start-
ing in 1991 largely because of reduced disinfection of 
drinking water. This relaxed attitude toward drinking 
water chlorination was partly due to U.S. reports about 
disinfection by-products in treated water.   Research in 
water purification today includes the use of ozone and 
ultraviolet radiation.1
Alexander Fleming discovered the antibiotic proper-
ties of penicillium notatum by accident in 1928. A stray 
spore of penicillium n. accidentally landed in a Petri 
dish that was prepared for a culture of Staphylococcus. 
After incubation, he noticed the presence of mold colo-
nies surrounded by a zone of growth inhibited staph. 
To further explore the properties of this mold, he grew 
penicillium n in a surface culture on a liquid medium. 
After a week, the liquid under the growing mold colony, 
which Fleming called penicillin, was harvested. The 
introduction of penicillin as a therapeutic drug for 
medical care on a large scale did not occur until the 
middle 1940s. Fleming’s penicillin was extremely dilute, 
Engineering has a long history of improving pub-lic health. One hundred years ago, chlorination of drinking water started in the United States at 
Jersey City, N.J.  In the beginning of the past century, 
local transportation was still by horses, even in the 
cities. As a result, animal waste was a major disposal 
problem and water-borne diseases such as cholera, 
typhoid, dysentery, and hepatitis A were killing about 
25 out of 100,000 people in the U.S. at the time. Today, 
these diseases are virtually eliminated in America, 
and this is largely due to the purification and distribu-
tion of clean drinking water. The use of filtration and 
chlorine to halt the spread of water-borne diseases is 
often considered the most significant public health ad-
vance in history. Chlorination works because chlorine 
is a strong oxidizing agent, which “breaks” down the 
cell walls of the bacteria in the water. Chlorine activity 
continues while the water is in storage tanks and pipes 
so that the bacteria cannot repopulate. Clean drinking 
water continues to be a great need in many parts of the 
developing world and the design and construction of 
purification and distribution systems presents a major 
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impure, and chemically unstable. In response to fire 
bombings in England during World War II, a group of 
Oxford University researchers improved the surface-
culture method to make enough penicillin for clinical 
trials. The dramatic effects of penicillin on wound 
healing convinced the Allies that the large-scale pro-
duction of penicillin would save the lives of thousands 
of servicemen. Chemical engineers, microbiologists, 
chemists, and biologists from universities, govern-
ment, and industry set out to mass produce penicillin. 
They searched for new strains of the mold and created 
mutant strains with ultraviolet light. They discovered 
better culture media. They invented a new purifica-
tion processes. Even freeze drying was explored as 
a means to stabilize the antibiotic. Perhaps the most 
important development was the shift from surface 
culture of the mold to submerged fermentation in huge 
tanks. Problems in heat and mass transfer and careful 
control of the environment inside the tanks needed 
to be solved. By 1944, 100,000 unit vials of penicil-
lin were coming off the end of the line at the Pfizer 
plant faster than they could be counted. The American 
Institute of Chemical Engineers considered the large-
scale production of penicillin to be one of the greatest 
chemical engineering achievements of the century. The 
development and production of therapeutic chemicals 
is important in chemical engineering today as bioengi-
neering represents a growth area.2
Imaging technology has come a long way from the 
X-ray. The ability to “see” what is happening inside 
the body can guide the diagnosis and effect the treat-
ment of illness. Signal processing and the graphical 
representation of information in a visual format have 
led to novel ways of producing medically useful im-
ages. Computed tomography (CT scans) take a series 
of X-ray images and computationally reconstructs a 
3D image. When my first child was born three decades 
ago, ultrasound imaging was fairly new. Now it is quite 
common. In my own family, ultrasound imaging has 
been used for prenatal care in pregnancy, amniocente-
sis, and echocardiograms. Magnetic resonance imag-
ing provides greater contrast between “soft” tissues 
than X-rays and has found widespread use in medicine 
exploring brain, heart muscle, and cancer tissues. In-
frared signals might be useful to detect breast cancer 
at a very early stage based on differences in the amount 
heat generated in cancer cells as opposed to normal 
tissue.3 Image signal processing and “machine vision” 
might be useful for examining light microscope slides 
for detecting differences between normal and diseased 
cells. Can image processing and computer simulations 
be used to create “medical simulators” like those used 
in the training of airplane pilots?
Computer simulations require quantitative math-
ematical models of physiological processes. My own 
experimental research has focused on peculiarities of 
blood flow in small vessels that are incorporated into 
computer simulations of blood flow in microvascular 
networks. These types of simulations are used to answer 
questions about hypertension, vessel remodeling, and 
drug delivery among others. The use of mathematics to 
describe physiological phenomena has the potential to 
quickly advance our understanding of both normal and 
pathological physiology.4
When faced with an unusual or interesting clinical 
case, sharing information with other physicians can 
be invaluable to a doctor. In teaching hospitals, Grand 
Rounds is a formal meeting where doctors discuss cur-
rent or interesting cases. Patients then receive input 
from several experienced medical personnel. This also 
increases the experience base of the doctors. Modern 
communications technology makes the sharing of in-
formation between doctors much easier. Today heart pa-
tients with an implanted cardio defibrillator can trans-
mit information from the implant over the telephone to 
their doctor. This is a step in providing real-time medi-
cal monitoring of the patient to the health professional.5 
Suppose EMTs could have access to information about 
prescription, allergies, etc. for victims when respond-
ing to emergencies. This could be done with a national 
medical database. What are the challenges of such an 
enterprise? Who is responsible for input of data? Who 
can have access to it? Who maintains the database once 
it is functioning? Can we protect patients’ privacy? 
Technologically, it appears feasible, but several social 
questions need answers.
Imagine instantaneous diagnosis from a drop of 
blood when the EMT arrives in response to a 911 call. 
This is known as point-of-care testing and is one of the 
dreams driving the development of a “lab-on-a-chip.” 
This is a Micro Mechanical Electric Systems, MEMS, 
device into which a drop of blood flows through a 
series of small channels, tens of microns in diameter, 
and chemical reactions are monitored to diagnose the 
condition of the patient. Such a device requires the un-
derstanding of micro-nano– manufacturing, fluid flow 
in very small channels (microfluidics), and chemical 
reaction at the micro scale. Although applications are 
limited today, great potential exists for the contribution 
of MEMS to health care delivery.6
Tissue engineering concerns the use of living cells to 
improve health. Can we engineer replacement tissues 
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for humans? The possibility is suggested by the discov-
ery of stem cells and growth factors and the idea of cell 
differentiation. One of the first growth factors, BMP 
(bone morphogenetic protein), spontaneously induced 
the growth of new bony tissue when placed in animals. 
Not surprisingly, bone and cartilage are two of the first 
applications of tissue engineering with therapeutic 
value. The most successful tissue engineered product 
is human skin equivalent by Organogenesis. This is 
a product made from two layers of cells in collagen. 
This product promotes healing for persistent wounds 
and promoted the migration of host skin cells into the 
wound to replace the transplanted cells. Other attempts 
at tissue engineering have not been as successful. After 
more than thirty years of effort, the search continues 
for a small bore artificial blood vessel, as well as for 
cellular-based therapies for liver, pancreas, and heart 
disease.8
The technical possibilities of engineering our way to 
good health are fascinating. There are many problems 
to overcome and the journey should be exciting. A final 
question, however, does need to be considered. Can 
engineering technology make health care more afford-
able? In many endeavors, the introduction of more and 
more technology has made things more affordable. The 
tremendous research efforts in agriculture have resulted 
in very affordable food crops in the U.S. Communica-
tions, transportation, and housing are more affordable 
because of the use of technology. Is the same true for 
health care? The inclusion of innovative technologies 
into health care delivery has been cited as a major driver 
of the increase in the cost of health care. Certainly, 
health care costs have risen with the inclusion of more 
innovation, but availability of services has also grown.9 
Finally, can we engineer our way to good health in a 
manner that we can afford?
Notes:
1.  The faculty involved with the Water Treatment 
Technology Center are very active in projects to maintain 
our access to healthy drinking water. Professors Ballestero, 
Collins, Jacobs, Kinner, and Malley of the Civil Engineering 
Department are very active in this research. One of the 
Environmental Engineering courses (ENE 740) is entitled 
Public Health Engineering.
2.  For a fascinating history of the development of penicillin 
in the 1940s see Chemical Engineering Progress Symposium 
Series Vol 66 No. 100 (Eng TP 1.A62 No.100). PT Vasudevan, 
chair of the Chemical Engineering Department, teaches 
a Biochemical Engineering course at UNH (ChE 761) and 
many of our graduates work in the biopharmaceutical indus-
try. Professor Vasudevan does important research in the area 
of enzyme kinetics and has developed a rapid assay for total 
blood cholesterol measurement.
3.  Processing and interpretation of signals interacting with 
biological systems is taught in Biomedical Instrumentation 
ECE 784. CT scanners were invented at EMI (Electric and 
Music Industries Ltd) in England. It is often said that the 
funding for this project came from the success of their mu-
sic recording business (Beatles, Beach Boys, etc.). Richard 
Messner of the Electrical and Computer Engineering 
Department is an expert on video image signal process and 
pattern recognition and has made attempts to automate the 
visual screening of malignant cells from Alzheimer’s pa-
tients. F. William Hersman, Physics Department, polarizes 
Xenon to enhance MRI images of the lung.
4.  See, for example, Annals of Biomedical Engineering vol. 
33 pp 764-771, 2005. Greg Chini, Mechanical Engineering 
Department, has done recent work on particle deposition 
and impingement on thin liquid films in the lung.
5.  Real-time monitoring of health parameters (vital signs) 
provides a measure of both wellness (normal state) and the 
onset of illness. The following video segment on the Internet 
may be interesting. http://spie.org/documents/newsroom/
videos/HaroldSzu.mov
6.  Nivedita Gupta, Chemical Engineering Department, has 
started a new course on Microfluidics ChE 722. The Material 
Science Program and the Chemistry Department participate 
in the Center for High-rate Nano-manufacturing, which is 
involved with MEMS devices.
7.  Scientific American April 1999 issue starting on page 59. 
An interesting note: Gary Bowlin, graduate of the Chemical 
Engineering Department, is very active in tissue engineer-
ing research at the Biomedical Engineering Department of 
Virginia Commonwealth University. http://www.egr.vcu.
edu/FacultyDetail.aspx?facid=5
8.  An interesting view of the price of penicillin is included 
in the Chemical Engineering Progress Symposium Series vol. 
66 No. 100 pp 20-21 mentioned earlier. Also see Annals of 
Internal Medicine 142:932-937, 2005 “High and Rising Health 
Care Costs. Part 2: Technological Innovation” for a recent 
analysis of technology-related health care costs.
